Naseem Zojwalla - Mar 18, 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Mar 18, 2024
Transactions value $
$66,719
Form type
4
Date filed
3/20/2024, 05:30 PM
Previous filing
Feb 5, 2024
Next filing
May 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Options Exercise $66.7K +13.7K +20.55% $4.87* 80.4K Mar 18, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -13.7K -9.13% $0.00 136K Mar 18, 2024 Common Stock 13.7K $4.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.